Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: Report of five cases and review of the literature

Dermatology

Volumn 225, Issue 2, 2012, Pages 163-167

  Osorio F ^a   Magro, F ^b,c   Lisboa, C ^a,c   Lopes, S ^b,c   MacEdo, G ^b,c   Bettencourt, H ^b   Azevedo, F ^a   Magina, S ^a,c  

^a Centro Hospitalar Universitário de São João   (Portugal)

^b Centro Hospitalar de Sao Joao EPE   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Alopecia; Anti tumor necrosis factor alpha; Psoriasis; Scalp; Scarring alopecia

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ALOPECIA; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; FAMILY HISTORY; FEMALE; HAIR GROWTH; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MALE; PANCYTOPENIA; PRIORITY JOURNAL; PSORIASIS; RECURRENT DISEASE; SCAR FORMATION; SKIN DEFECT; SYSTEMIC THERAPY; TOPICAL TREATMENT; TREATMENT RESPONSE;

ADULT; ALOPECIA; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; PSORIASIS; SCALP; SCALP DERMATOSES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84870812558     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000342503     Document Type: Article

References (14)

1. Cullen G, Kroshinsky D, Cheifetz AS, Korzenik JR: Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature. Aliment Pharmacol Ther 2011; 34: 1318-1327.
2. Collamer AN, Battafarano DF: Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010; 40: 233-240.
3. El Shabrawi-Caelen L, La Placa M, Vincenzi C, Haidn T, Muellegger R, Tosti A: Adalimumab-induced psoriasis of the scalp with diffuse alopecia: a severe potentially irreversible cutaneous side effect of TNF-alpha blockers. Inflamm Bowel Dis 2010; 16: 182-183.
4. Manni E, Barachini P: Psoriasis induced by infliximab in a patient suffering from Crohn's disease. Int J Immunopathol Pharmacol 2009; 22: 841-844.
5. Papadavid E, Gazi S, Dalamaga M, Stavrianeas N, Ntelis V: Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management. J Eur Acad Dermatol Venereol 2008; 22: 380-382.
6. Perman MJ, Lovell DJ, Denson LA, Farrell MK, Lucky AW: Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children. Pediatr Dermatol 2012; 29: 454-459.
7. Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J: Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 2005; 102: 3372-3377.
8. Ko JM, Gottlieb AB, Kerbleski JF: Induction and exacerbation of psoriasis with TNFblockade therapy: a review and analysis of 127 cases. J Dermatolog Treat 2009; 20: 100-108.
9. Wollina U, Hansel G, Koch A, Schonlebe J, Kostler E, Haroske G: Tumor necrosis factoralpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 2008; 9: 1-14.
10. Rahier JF, Buche S, Peyrin-Biroulet L, Bouhnik Y, Duclos B, Louis E, Papay P, Allez M, Cosnes J, Cortot A, Laharie D, Reimund JM, Lemann M, Delaporte E, Colombel JF: Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol 2010; 8: 1048-1055.
11. Toda N, Fujimoto N, Kato T, Fujii N, Nakanishi G, Nagao T, Tanaka T: Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors. Dermatology 2012, Epub ahead of print.
12. Harrison MJ, Dixon WG, Watson KD, King Y, Groves R, Hyrich KL, Symmons DP: Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving antitumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2009; 68: 209-215.
13. Baumgart DC, Grittner U, Steingraber A, Azzaro M, Philipp S: Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients. Inflamm Bowel Dis 2011; 17: 2512-2520.
14. Medkour F, Babai S, Chanteloup E, Buffard V, Delchier JC, Le-Louet H: Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab. Gastroenterol Clin Biol 2010; 34: 140-141.